Frontiers in Immunology (Oct 2022)
Describing immune factors associated with Hepatitis B surface antigen loss: A nested case-control study of a Chinese sample from Wuwei City
- Xiaojie Yuan,
- Xiaojie Yuan,
- Ting Fu,
- Ting Fu,
- Lixin Xiao,
- Lixin Xiao,
- Zhen He,
- Zhen He,
- Zhaohua Ji,
- Zhaohua Ji,
- Samuel Seery,
- Wenhua Zhang,
- Yancheng Ye,
- Haowei Zhou,
- Haowei Zhou,
- Xiangyu Kong,
- Xiangyu Kong,
- Shuyuan Zhang,
- Shuyuan Zhang,
- Qi Zhou,
- Qi Zhou,
- Yulian Lin,
- Yulian Lin,
- Wenling Jia,
- Chunhui Liang,
- Haitao Tang,
- Fengmei Wang,
- Weilu Zhang,
- Weilu Zhang,
- Zhongjun Shao,
- Zhongjun Shao
Affiliations
- Xiaojie Yuan
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Xiaojie Yuan
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Ting Fu
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Ting Fu
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Lixin Xiao
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Lixin Xiao
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Zhen He
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Zhen He
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Zhaohua Ji
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Zhaohua Ji
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Samuel Seery
- Faculty of Health and Medicine, Division of Health Research, Lancaster University, Lancaster, United Kingdom
- Wenhua Zhang
- Clinical Drug Experiment Institution, Gansu Wuwei Tumor Hospital, Wuwei, China
- Yancheng Ye
- Hepatobiliary Center, Gansu Wuwei Tumor Hospital, Wuwei, China
- Haowei Zhou
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Haowei Zhou
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Xiangyu Kong
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Xiangyu Kong
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Shuyuan Zhang
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Shuyuan Zhang
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Qi Zhou
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Qi Zhou
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Yulian Lin
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Yulian Lin
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Wenling Jia
- Clinical Drug Experiment Institution, Gansu Wuwei Tumor Hospital, Wuwei, China
- Chunhui Liang
- Clinical Drug Experiment Institution, Gansu Wuwei Tumor Hospital, Wuwei, China
- Haitao Tang
- Clinical Drug Experiment Institution, Gansu Wuwei Tumor Hospital, Wuwei, China
- Fengmei Wang
- Clinical Drug Experiment Institution, Gansu Wuwei Tumor Hospital, Wuwei, China
- Weilu Zhang
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Weilu Zhang
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- Zhongjun Shao
- Department of Epidemiology, School of Public Health, Air Force Medical University, Xi’an, China
- Zhongjun Shao
- Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi’an, China
- DOI
- https://doi.org/10.3389/fimmu.2022.1025654
- Journal volume & issue
-
Vol. 13
Abstract
BackgroundHepatitis B surface antigen (HBsAg) loss is considered a functional cure for chronic hepatitis B (CHB), however, several factors influence HBsAg loss.Methods29 CHB patients who had achieved HBsAg loss, were selected and 58 CHB patients with persistent HBsAg were matched, according to gender and age (+/- 3 years). Logistic regression and restricted cubic spline (RCS) modelling were performed.ResultsMultivariate-adjusted logistic regression, based on stepwise selection, showed that baseline HBsAg levels negatively correlated with HBsAg loss (odds ratio [OR] = 0.99, 95% confidence interval [CI] = 0.98-0.99). Interferon treatment positively related with HBsAg loss (OR = 7.99, 95%CI = 1.62-44.88). After adjusting for age, HBsAg level, ALT level, HBeAg status and interferon treatment, MMP-1 (OR = 0.66, 95%CI = 0.44-0.97), CXCL9 (OR = 0.96, 95%CI = 0.93-0.99) and TNF-R1 (OR = 0.97, 95%CI = 0.94-0.99) baseline levels all negatively correlated with HBsAg loss. Our multivariate-adjusted RCS model showed that baseline CXCL10 was associated with HBsAg loss although the relationship was “U-shaped”.ConclusionsCytokines such as MMP-1, CXCL9, CXCL10 and TNF-R1 are important factors which influence HBsAg loss. It may be possible to develop a nomogram which intercalates these factors; however, further research should consider immune processes involved in HBsAg loss.
Keywords